Browsing by Yonsei Author : Shin, Sang Joon

eperson profile image
Name:
Shin, Sang Joon [신상준]
orcid http://orcid.org/0000-0001-5350-7241
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (7403647334)

Keyword Cloud

Researcher Network

Showing results 51 to 100 of 178

This table browses all dspace content
Issue DateTitleJournal Title
2021Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma JOURNAL OF CLINICAL ONCOLOGY
2021Autonomy is not but competence and relatedness are associated with physical activity among colorectal cancer survivorsSUPPORTIVE CARE IN CANCER
2021Effect of Itraconazole, a Potent CYP3A4 Inhibitor, on the Steady-State Pharmacokinetics of Vemurafenib in Patients With BRAFV600 Mutation-Positive MalignanciesCLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT
2021Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score Analysis FRONTIERS IN ONCOLOGY
2020Clinical features and KRAS mutation in colorectal cancer with bone metastasis SCIENTIFIC REPORTS
2020A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal MetastasesCLINICAL COLORECTAL CANCER
2020Male sex and Breslow thickness are important risk factors for recurrence of localized melanoma in Korean populationsJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
2020Open-label, phase IIa study of dabrafenib plus trametinib in East Asian patients with advanced BRAF V600-mutant cutaneous melanomaEUROPEAN JOURNAL OF CANCER
2020Clinical Significance of Preoperative Serum Carcinoembryonic Antigen Within the Normal Range in Colorectal Cancer Patients Undergoing Curative ResectionANNALS OF SURGICAL ONCOLOGY
2020Clinical Outcomes of Immune Checkpoint Blocker Therapy for Malignant Melanoma in Korean Patients: Potential Clinical Implications for a Combination Strategy Involving Radiotherapy CANCER RESEARCH AND TREATMENT
2020Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours BRITISH JOURNAL OF CANCER
2020Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial TRIALS
2020Efficacy and Tolerability of Tremelimumab in Locally Advanced or Metastatic Urothelial Carcinoma Patients Who Have Failed First-Line Platinum-Based ChemotherapyCLINICAL CANCER RESEARCH
2020Objectively measured physical activity during chemotherapy in colon cancer patientsSUPPORTIVE CARE IN CANCER
2019위장관암 환자의 옥살리플라틴 항암화학요법으로 인한 말초신경병증, 증상경험, 디스트레스와 삶의 질 ASIAN ONCOLOGY NURSING
2019VEGF-A drives TOX-dependent T cell exhaustion in anti-PD-1-resistant microsatellite stable colorectal cancersScience Immunology
2019Effect of Radiotherapy Combined With Pembrolizumab on Local Tumor Control in Mucosal Melanoma Patients Frontiers in Oncology
2019Treatment Outcomes of Re-irradiation in Locoregionally Recurrent Rectal Cancer and Clinical Significance of Proper Patient Selection Frontiers in Oncology
2019Screening for Lung Cancer Using Low-dose Chest Computed Tomography in Korean Long-term Colorectal Cancer Survivors Journal of Cancer Prevention
2018The role of endoscopic evaluation for radiation proctitis in patients receiving intermediate-dose postoperative radiotherapy for rectal cancer.JAPANESE JOURNAL OF CLINICAL ONCOLOGY
2018CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer YONSEI MEDICAL JOURNAL
2018IL21 Therapy Combined with PD-1 and Tim-3 Blockade Provides Enhanced NK Cell Antitumor Activity against MHC Class I-Deficient Tumors.CANCER IMMUNOLOGY RESEARCH
2018Activation of NKT Cells in an Anti-PD-1-Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells.CANCER RESEARCH
2018Prognoses and Clinical Outcomes of Primary and Recurrent Uveal Melanoma. CANCER RESEARCH AND TREATMENT
2018Genetic Alterations among Korean Melanoma Patients Showing Tumor Heterogeneity: A Comparison between Primary Tumors and Corresponding Metastatic Lesions. CANCER RESEARCH AND TREATMENT
2018Predictive Nomogram for Recurrence of Stage I Colorectal Cancer After Curative ResectionCLINICAL COLORECTAL CANCER
2018Mapping of lateral pelvic lymph node recurrences in rectal cancer: a radiation oncologist's perspectiveJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2018YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant MelanomaCANCER IMMUNOLOGY RESEARCH
2017Sunrise in melanoma management: Time to focus on melanoma burden in AsiaASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
2017A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumorsINVESTIGATIONAL NEW DRUGS
2017Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibitionONCOGENE
2017IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours NATURE COMMUNICATIONS
2017Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery BMC CANCER
2017Reduced pelvic field sparing anastomosis for postoperative radiotherapy in selected patients with mid-upper rectal cancer JOURNAL OF RADIATION RESEARCH
2017Quality of life among Korean gastrointestinal cancer survivors EUROPEAN JOURNAL OF ONCOLOGY NURSING
2017Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer ONCOLOGY LETTERS
2017Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients AMERICAN JOURNAL OF CANCER RESEARCH
2017Ipilimumab Real-World Efficacy and Safety in Korean Melanoma Patients from the Korean Named-Patient Program Cohort CANCER RESEARCH AND TREATMENT
2017Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon CancerANNALS OF SURGICAL ONCOLOGY
2016Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal CancerANNALS OF SURGICAL ONCOLOGY
2016Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratificationJAPANESE JOURNAL OF CLINICAL ONCOLOGY
2016Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Surrogate Biomarker for Bevacizumab in Colorectal Cancer Liver Metastasis: A Single-Arm, Exploratory Trial CANCER RESEARCH AND TREATMENT
2016Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancersBRITISH JOURNAL OF CANCER
2016A New Practical Desensitization Protocol for Oxaliplatin-Induced Immediate Hypersensitivity Reactions: A Necessary and Useful Approach JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
2016High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancerJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2016Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable Prognostic Factors PLOS ONE
2016Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy ONCOTARGET
2016A phase II study of preoperative mFOLFOX6 with short-course radiotherapy in patients with locally advanced rectal cancer and liver-only metastasisRADIOTHERAPY AND ONCOLOGY
2016p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer CANCER RESEARCH AND TREATMENT
2015A Randomized Phase 2 Study of Neoadjuvant Chemoradiaton Therapy With 5-Fluorouracil/Leucovorin or Irinotecan/S-1 in Patients With Locally Advanced Rectal CancerINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Browse

Links